AbbVie price target lowered to $208 from $228 at BMO Capital
6 days ago · BMO Capital analyst Evan Seigerman lowered the firm’s price target on AbbVie to $208 from $228 and keeps an Outperform rating on the shares.The firm is citing EMPOWER 1 …
OFF
AbbVie Price Target Lowered To $208 From $228 At BMO Capital
1 week from now
6 days ago · BMO Capital analyst Evan Seigerman lowered the firm’s price target on AbbVie to $208 from $228 and keeps an Outperform rating on the shares.The firm is citing EMPOWER 1 …
businessinsider.com
OFF
BMO Capital Markets Lowers AbbVie (NYSE:ABBV) Price Target To …
1 week from now
2 days ago · AbbVie (NYSE:ABBV – Free Report) had its price target cut by BMO Capital Markets from $228.00 to $208.00 in a report released on Tuesday,Benzinga reports. They currently …
americanbankingnews.com
OFF
AbbVie Stock Target Cut, Rating Continued On Trial Results
1 week from now
6 days ago · On Tuesday, BMO Capital Markets adjusted its outlook on AbbVie (NYSE:ABBV) shares by reducing the price target to $208 from the previous $228. The firm has maintained …
investing.com
OFF
AbbVie Price Target Raised To $220 From $214 At BMO Capital
1 week from now
Oct 18, 2024 · BMO Capital raised the firm’s price target on AbbVie to $220 from $214 and keeps an Outperform rating on the shares as part of a broader research note previewing Q3 results …
yahoo.com
OFF
A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts
1 week from now
Jul 2, 2024 · Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $190.29, accompanied by a high estimate of $200.00 and a low estimate of …
businessinsider.com
OFF
AbbVie (NYSE:ABBV) Price Target Increased To $220.00 By Analysts …
1 week from now
Oct 17, 2024 · AbbVie (NYSE:ABBV - Free Report) had its target price lifted by BMO Capital Markets from $214.00 to $220.00 in a research report report published on Thursday, Benzinga …
marketbeat.com
OFF
AbbVie Hold Rating Maintained Amid Emraclidine Trial
1 week from now
5 days ago · Bristol Myers price target raised to $61 from $57 at BMO Capital Nvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls AbbVie price target lowered to $208 from …
businessinsider.com
OFF
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
1 week from now
Oct 7, 2024 · Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $208.09, accompanied by a high estimate of $225.00 and a low estimate of …
nasdaq.com
OFF
BMO Increases AbbVie Stock Target, Outperform On Upbeat …
1 week from now
On Thursday, BMO Capital Markets adjusted its outlook on AbbVie Inc . (NYSE: ABBV) shares, a research-based biopharmaceutical company, by increasing the stock's price target to $228 …
investing.com
OFF
BMO Boosts Abbvie Shares Target Amid Positive Revenue Outlook
1 week from now
On Friday, BMO Capital Markets maintained an Outperform rating on Abbvie (NYSE:ABBV) stock and increased the shares target to $214 from the previous $180.
investing.com
OFF
AbbVie (ABBV) Stock Forecast And Price Target 2024 - MarketBeat
1 week from now
3 days ago · BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating : Lower Target: ... Lower Target: $170.00 $160.00 +18.02%: 2/10/2023: ...
marketbeat.com
OFF
BMO Boosts Abbvie Shares Target Amid Positive Revenue Outlook
1 week from now
Jul 19, 2024 · On Friday, BMO (TSX: BMO) Capital Markets maintained an Outperform rating on Abbvie (NYSE:ABBV) stock and increased the shares target to $214 from the previous $180. …
investing.com
OFF
JPMorgan Trims AbbVie Target, Removes From Analyst Focus List
1 week from now
5 days ago · JPMorgan lowered the firm’s price target on AbbVie (ABBV) to $200 from $210 and keeps an Overweight rating on the shares. While the emracl...
businessinsider.com
OFF
BMO Capital Markets Has Lowered Expectations For AbbVie …
1 week from now
4 days ago · AbbVie (NYSE:ABBV – Get Free Report) had its price target decreased by analysts at BMO Capital Markets from $228.00 to $208.00 in a research report issued on …
etfdailynews.com
OFF
Mutual Of America Capital Management LLC Has $46.17
1 week from now
1 day ago · Mutual of America Capital Management LLC lowered its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 2.4% in the third quarter, according to the company in its most …
marketbeat.com
OFF
BMO Capital Markets Has Lowered Expectations For Boralex …
1 week from now
1 day ago · BMO Capital Markets reduced their target price on shares of Boralex from C$46.00 to C$45.00 in a research note on Friday. ... BMO Capital Markets Has Lowered Expectations for …
marketbeat.com
OFF
BMO Capital Markets Has Lowered Expectations For Dorel …
1 week from now
1 day ago · BMO Capital Markets decreased their price objective on shares of Dorel Industries from C$7.00 to C$5.00 in a report on Friday. ... BMO Capital Markets Has Lowered …
marketbeat.com
FAQs about AbbVie price target lowered to $208 from $228 at BMO Capital Coupon?
What is the price target for AbbVie (abbv)?
Should you buy AbbVie (abbv)?
Is AbbVie a good stock to buy?
Why did AbbVie increase its profit forecast for 2024?
Is AbbVie (ABV) stock overvalued?
Will AbbVie's emraclidine Phase 2 data affect sales estimates?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
